Panacea Biotec has received a Letter of Acceptance (LoA) worth Rs 127.2 crore on October 08, 2025 from Central Medical Services Society, Ministry of Health and Family Welfare, Government of India (CMSS) for supply of bivalent oral polio vaccines (bOPV). As per the LoA, the company will supply the vaccine in several tranches over a period of 90-480 days from the date of issuance of LoA.
Panacea Biotec is a leading research-based Biotechnology Company with established research, manufacturing and marketing capabilities.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: